Michael Thomas Heffernan, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 100,150 shares at $25.88 ($2.5M) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Seasonal sale ($2.5M) by Director — this insider has traded COLL in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.26 | 47,044 | $1.2M | 46.9% |
| 2 | $25.26 | 47,044 | $1.2M | 46.9% |
| 3 | $25.88 | 3,031 | $78K | 3.1% |
| 4 | $25.88 | 3,031 | $78K | 3.1% |
| Total | $25.30 avg | 100,150 | $2.5M | 100% |
| Filing → |
| COLL | SELL | 2022-12-14 | $8.4M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |
| COLL | SELL | 2020-05-15 | $804K | — | Filing → |